Headshot of Mary Doherty.

Mary Doherty

Consultant anaesthetist
Our Lady’s Hospital, Navan, Ireland

Mary Doherty is an autistic consultant anesthesiologist based in Ireland, an honorary clinical research fellow at Brighton & Sussex Medical School in the United Kingdom, and a Ph.D. student at London South Bank University. She is also the mother of two neurodivergent young people.

Doherty is founder of Autistic Doctors International and Autistic Med Students, both dedicated to peer support, advocacy, research and training. She has been involved with biomedical autism research for several years, as a member of the AIMS-2-Trials Autism Representatives Steering Committee and more recently the Participatory Research Advisory Committee for the RESPECT 4 Neurodevelopment Network.

Her research interests include health care for autistic adults and the experiences of autistic medical students and doctors. Her doctoral research focuses on the experiences and perspectives of autistic psychiatrists.

From this contributor

Photograph of a woman in a dim room looking out her window.
Spectrum

Weaponized heterogeneity only harms the most vulnerable autistic people

By Mary Doherty
17 April 2023 | 8 min read

Explore more from The Transmitter

Illustration of lucid dreaming.
Perception

Watching the mind build a world: Lucid dreaming as a model for generative perception

Lucid dreaming offers a rare opportunity to observe and probe perception from within.

By Magdalena Paluchowska
13 July 2026 | 8 min read
Two lab mice fighting.
Social behavior

From friend to foe: How the brain updates feelings toward others

A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.

By Natalia Mesa
9 July 2026 | 5 min read
Illustration of scientist in lab coat looking at shelves of computer network models.
Artificial intelligence

Mass-produced science is coming. What happens to scientists?

Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.

By Kenneth Harris
9 July 2026 | 9 min read